These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 22734518

  • 1. Sufficient virus-neutralizing antibody in the central nerve system improves the survival of rabid rats.
    Liao PH, Yang HH, Chou PT, Wang MH, Chu PC, Liu HL, Chen LK.
    J Biomed Sci; 2012 Jun 26; 19(1):61. PubMed ID: 22734518
    [Abstract] [Full Text] [Related]

  • 2. Enhancement of blood-brain barrier permeability and reduction of tight junction protein expression are modulated by chemokines/cytokines induced by rabies virus infection.
    Chai Q, He WQ, Zhou M, Lu H, Fu ZF.
    J Virol; 2014 May 26; 88(9):4698-710. PubMed ID: 24522913
    [Abstract] [Full Text] [Related]

  • 3. Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system.
    Phares TW, Kean RB, Mikheeva T, Hooper DC.
    J Immunol; 2006 Jun 15; 176(12):7666-75. PubMed ID: 16751414
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of blood-brain barrier permeability is required for intravenously administered virus neutralizing antibodies to clear an established rabies virus infection from the brain and prevent the development of rabies in mice.
    Huang CT, Li Z, Huang Y, Zhang G, Zhou M, Chai Q, Wu H, Fu ZF.
    Antiviral Res; 2014 Oct 15; 110():132-41. PubMed ID: 25108172
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity.
    Fabis MJ, Phares TW, Kean RB, Koprowski H, Hooper DC.
    Proc Natl Acad Sci U S A; 2008 Oct 07; 105(40):15511-6. PubMed ID: 18829442
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immune evasion by rabies viruses through the maintenance of blood-brain barrier integrity.
    Roy A, Hooper DC.
    J Neurovirol; 2008 Oct 07; 14(5):401-11. PubMed ID: 19016377
    [Abstract] [Full Text] [Related]

  • 9. Viral Infection of the Central Nervous System and Neuroinflammation Precede Blood-Brain Barrier Disruption during Japanese Encephalitis Virus Infection.
    Li F, Wang Y, Yu L, Cao S, Wang K, Yuan J, Wang C, Wang K, Cui M, Fu ZF.
    J Virol; 2015 May 07; 89(10):5602-14. PubMed ID: 25762733
    [Abstract] [Full Text] [Related]

  • 10. T-bet Is Required for the Rapid Clearance of Attenuated Rabies Virus from Central Nervous System Tissue.
    Lebrun A, Portocarrero C, Kean RB, Barkhouse DA, Faber M, Hooper DC.
    J Immunol; 2015 Nov 01; 195(9):4358-68. PubMed ID: 26408670
    [Abstract] [Full Text] [Related]

  • 11. Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier.
    Roy A, Hooper DC.
    J Virol; 2007 Aug 01; 81(15):7993-8. PubMed ID: 17507463
    [Abstract] [Full Text] [Related]

  • 12. Intracerebral administration of recombinant rabies virus expressing GM-CSF prevents the development of rabies after infection with street virus.
    Wang H, Zhang G, Wen Y, Yang S, Xia X, Fu ZF.
    PLoS One; 2011 Aug 01; 6(9):e25414. PubMed ID: 21980450
    [Abstract] [Full Text] [Related]

  • 13. Lab-Attenuated Rabies Virus Facilitates Opening of the Blood-Brain Barrier by Inducing Matrix Metallopeptidase 8.
    Fang A, Yuan Y, Huang F, Wang C, Tian D, Zhou R, Zhou M, Chen H, Fu ZF, Zhao L.
    J Virol; 2022 Sep 14; 96(17):e0105022. PubMed ID: 36005758
    [Abstract] [Full Text] [Related]

  • 14. Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system.
    Hooper DC, Morimoto K, Bette M, Weihe E, Koprowski H, Dietzschold B.
    J Virol; 1998 May 14; 72(5):3711-9. PubMed ID: 9557653
    [Abstract] [Full Text] [Related]

  • 15. Revisiting rabies virus neutralizing antibodies through infecting BALB/c mice with live rabies virus.
    Qin Y, Smith TG, Jackson F, Gallardo-Romero NF, Morgan CN, Olson V, Hutson CL, Wu X.
    Virus Res; 2018 Mar 15; 248():39-43. PubMed ID: 29471052
    [Abstract] [Full Text] [Related]

  • 16. Mannitol treatment is not effective in therapy of rabies virus infection in mice.
    Dufkova L, Sirmarova J, Salat J, Honig V, Palus M, Ruzek D, Fooks AR, Mansfield KL, Tordo N, Jochmans D, Neyts J, Martina B, Koraka P, Osterhaus ADME, ASKLEPIOS consortium.
    Vaccine; 2019 Aug 02; 37(33):4710-4714. PubMed ID: 29274698
    [Abstract] [Full Text] [Related]

  • 17. The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system.
    Hooper DC, Phares TW, Fabis MJ, Roy A.
    PLoS Negl Trop Dis; 2009 Oct 06; 3(10):e535. PubMed ID: 19806203
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of chemokine-like factor 1 improves blood-brain barrier dysfunction in rats following focal cerebral ischemia.
    Kong LL, Wang ZY, Hu JF, Yuan YH, Li H, Chen NH.
    Neurosci Lett; 2016 Aug 03; 627():192-8. PubMed ID: 27283776
    [Abstract] [Full Text] [Related]

  • 19. Role of the blood-brain barrier in rabies virus infection and protection.
    Wang L, Cao Y, Tang Q, Liang G.
    Protein Cell; 2013 Dec 03; 4(12):901-3. PubMed ID: 24264143
    [Abstract] [Full Text] [Related]

  • 20. Presence of virus neutralizing antibodies in cerebral spinal fluid correlates with non-lethal rabies in dogs.
    Gnanadurai CW, Zhou M, He W, Leyson CM, Huang CT, Salyards G, Harvey SB, Chen Z, He B, Yang Y, Hooper DC, Dietzchold B, Fu ZF.
    PLoS Negl Trop Dis; 2013 Dec 03; 7(9):e2375. PubMed ID: 24069466
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.